Please login to the form below

Not currently logged in
Email:
Password:

dermatitis

This page shows the latest dermatitis news and features for those working in and with pharma, biotech and healthcare.

Sanofi/Regeneron’s Dupixent gets US label update for atopic dermatitis

Sanofi/Regeneron’s Dupixent gets US label update for atopic dermatitis

Dupixent’s label now includes data supporting its use in hand and foot atopic dermatitis. ... Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) has approved a label update for Dupixent (dupilumab) in atopic dermatitis.

Latest news

More from news
Approximately 38 fully matching, plus 113 partially matching documents found.

Latest Intelligence

  • The impact of creativity in healthcare The impact of creativity in healthcare

    So let’s hear it for the Blood Normals of the world, for the Emma Work Colleague of the Future campaign and to LEO Pharma for portraying what atopic dermatitis looks

  • Can the patient pathway provide a route to success? Can the patient pathway provide a route to success?

    Recognising that the challenges of living with atopic dermatitis are far from skin deep, Sanofi launched a global grants initiative called ‘Agents of Change’. ... a spotlight on some of the real day-to-day challenges faced by those with atopic

  • How AI is finally helping rare diseases gain more than just attention How AI is finally helping rare diseases gain more than just attention

    That’s the approach companies like BenevolentAI have taken. Its treatment for atopic dermatitis is now in phase 2 clinical trials and was discovered using machine learning technology.

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    pneumococcal vaccine due to be filed next year that would extend its $3.4bn Prevnar franchise, a Clostridium difficile vaccine in phase 3 and JAK inhibitors for atopic dermatitis and alopecia.

  • Case study: See Below Case study: See Below

    We needed to pique delegates’ interest and show them a new approach to treating atopic dermatitis. ... But, how? Before diving head-first into the idea, we enlisted the help of key stakeholders within atopic dermatitis.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

The evolving healthcare advertising landscape
Industry experts share their insights on the emerging trends in healthcare advertising...
Clinical trial considerations: Why supporting HCPs matters...
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone....
Six ways to provide successful e-learning programs to healthcare professionals
Practical tips to setting up high-impact e-learning programs...